Delivery Order SPE2DB20D2104-SPE2DB25FNAGC
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Gel-One 30 mg/3 mL syringes with a ceiling value of $5,473.50. This firm fixed price delivery order, with an ultimate completion date of September 12, 2025, represents a competitive award with no set-aside designation. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. As a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a $14,596 delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Gel-One 30 mg/3 mL syringes. The contract, which is competitively awarded with no set-aside designation, carries a firm fixed price structure and an ultimate completion date of September 10, 2025. AmerisourceBergen will fulfill this order from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a leading...
- The Defense Logistics Agency awarded a delivery order valued at $4.38K to AmerisourceBergen Drug Corp for the supply of Gel-One 30 mg/3 ml syringes on September 8, 2025, with completion expected by September 29, 2025. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $1 billion prime vendor agreement (SPE2DX) extending through December 2026. The contract employs firm fixed-price pricing and was competitively...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Gel-One 30 mg/3 mL syringes with a ceiling value of $1,459.60. This competitively awarded, firm fixed-price delivery order is classified as a child contract and represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal medical procurement. The product will be performed at the company's headquarters location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Gel-One 30 mg/3 mL syringes with a ceiling value of $1,094.70. This is a firm fixed-price delivery order with an ultimate completion date of September 8, 2025, and represents a non-set-aside competitive award. The order will be fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania, the company's corporate headquarters. This delivery order is issued...
- The Defense Logistics Agency awarded a $9,122.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Gel-One 30 mg/3 mL syringes on September 12, 2025, with completion targeted for October 3, 2025. This non-competitive delivery order represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The work will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,649.00 to AmerisourceBergen Drug Corp for the supply of Gel-One 30 mg/3 mL syringes. This firm fixed-price delivery order, issued on August 4, 2025, with an ultimate completion date of August 25, 2025, represents a competitive award with no set-aside designation. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. As a child order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,649 to AmerisourceBergen Drug Corp for Gel-One 30 mg/3 mL syringes on August 5, 2025, with completion scheduled for August 26, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a single pharmaceutical supply transaction within the company's broader federal contract portfolio. The product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,947.00 to AmerisourceBergen Drug Corp for the supply of Gel-One 30 mg/3 ml syringes. This non-set-aside, firm fixed-price delivery order was competitively awarded on September 3, 2025, with an ultimate completion date of September 24, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,824.50 to AmerisourceBergen Drug Corp for the supply of Gel-One 30 mg/3 mL syringes on July 30, 2025, with an ultimate completion date of August 20, 2025. This competitive contract award, which carries no set-aside designation, is structured as a firm fixed price delivery order. The product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FNAGCDelivery Order
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $7,298.00 by the Defense Logistics Agency (DLA) on September 12, 2025, for the supply of Gel-One 30 mg/3 mL syringes (3 mL quantity). The contract carries a firm fixed price structure with no set-aside designation and an ultimate completion date of October 3, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as the company's comprehensive vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp fulfills a wide range of medical supply needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's track record demonstrates consistent capability in competitive federal procurement across multiple therapeutic domains, from specialty medications to medical devices and supplies. This specific delivery order for Gel-One, a hyaluronic acid-based injectable product commonly used in orthopedic and ophthalmologic applications, exemplifies the company's role in supporting military medical readiness and veteran healthcare initiatives through the DLA's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.3k | 9/12/25 |